Surgical eye company announces financial results

STAAR Surgical, a company headquartered in Lake Forest will be announcing its fourth-quarter and full-year earnings for 2019 next month.

The company focuses on ophthalmic surgery and designs, develops, manufactures, and markets implantable lenses for the eye, with associated delivery systems.

In its preliminary statements, the company announced that its net sales for the fourth quarter will be close to $39m, and $150.2m for the fiscal year. These figures are $1m each above those the company provided in its outlook in November. Print shops are often hired to create formal documents for distribution with such announcements.

STAAR expects that over the fiscal year 2020, the company will grow in the range of 16-20% percent, translating into total net sales of approximately $177.2m for the fiscal year. Its compound annual growth rate for the fiscal 2020-2022 three-year planning period is expected to be 25%.

President and CEO of STAAR Surgical, Caren Mason, said that these preliminary results show that the company can deliver on its stated financial commitments, which reflect its ability to increase its market share for its refractive vision correction solutions. Mason added that the company can now focus on achieving the operating and financial targets it has planned for the next three years.

STARR will announce its complete financial results on Wednesday, February 26.
Get a Free Quote for Print